Literature DB >> 11125889

Immunolocalization of HIV envelope gp120 in HIV encephalitis with dementia.

M V Jones1, J E Bell, A Nath.   

Abstract

Numerous studies have shown that the HIV envelope glycoprotein, gp120, is a potent neurotoxin. However, its role in the pathogenesis of HIV dementia had been questioned due to the lack of demonstration of its presence in vivo. We now demonstrate conclusively the presence of gp120 by immunohistochemistry in the brain of patients with HIV encephalitis who also had dementia. A highly specific anti-gp120 polyclonal sera was used on formalin fixed tissue. Gp120 staining cells were predominantly perivascular and included macrophages, microglia and multinucleated giant cells. These studies provide an important missing link for the role of gp120 in the neuropathogenesis of HIV infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11125889     DOI: 10.1097/00002030-200012010-00010

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  59 in total

1.  HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication.

Authors:  Claudia Cicala; James Arthos; Sara M Selig; Glynn Dennis; Douglas A Hosack; Donald Van Ryk; Marion L Spangler; Tavis D Steenbeke; Prateeti Khazanie; Neil Gupta; Jun Yang; Marybeth Daucher; Richard A Lempicki; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-27       Impact factor: 11.205

2.  Preferential sensitivity of human dopaminergic neurons to gp120-induced oxidative damage.

Authors:  Shuxian Hu; Wen S Sheng; James R Lokensgard; Phillip K Peterson; R Bryan Rock
Journal:  J Neurovirol       Date:  2009-09       Impact factor: 2.643

3.  Neonatal intrahippocampal gp120 injection: an examination early in development.

Authors:  Sylvia Fitting; Rosemarie M Booze; Charles F Mactutus
Journal:  Neurotoxicology       Date:  2006-07-31       Impact factor: 4.294

4.  Failure of HIV-exposed CD4+ T cells to activate dendritic cells is reversed by restoration of CD40/CD154 interactions.

Authors:  Rui Zhang; Jeffrey D Lifson; Claire Chougnet
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

5.  Dopaminergic marker proteins in the substantia nigra of human immunodeficiency virus type 1-infected brains.

Authors:  Janelle M Silvers; Michael Y Aksenov; Marina V Aksenova; Jacob Beckley; Petra Olton; Charles F Mactutus; Rosemarie M Booze
Journal:  J Neurovirol       Date:  2006-04       Impact factor: 2.643

6.  Immunodetection of human immunodeficiency virus type 1 (HIV-1) Vpr in brain tissue of HIV-1 encephalitic patients.

Authors:  Elizabeth D A Wheeler; Cristian L Achim; Velpandi Ayyavoo
Journal:  J Neurovirol       Date:  2006-06       Impact factor: 2.643

7.  Functional interaction between HIV-gp120 and opioid system in the preoptic anterior hypothalamus.

Authors:  Jonathan Palma; Mary E Abood; Mary F Barbe; Khalid Benamar
Journal:  Drug Alcohol Depend       Date:  2013-09-26       Impact factor: 4.492

8.  HIV-associated motor neuron disease: HERV-K activation and response to antiretroviral therapy.

Authors:  Lauren N Bowen; Richa Tyagi; Wenxue Li; Tariq Alfahad; Bryan Smith; Mary Wright; Elyse J Singer; Avindra Nath
Journal:  Neurology       Date:  2016-09-24       Impact factor: 9.910

9.  HIV-gp120 and physical dependence to buprenorphine.

Authors:  J Palma; M E Abood; K Benamar
Journal:  Drug Alcohol Depend       Date:  2015-02-26       Impact factor: 4.492

10.  Phosphatidylcholine-specific phospholipase C activation is required for CCR5-dependent, NF-kB-driven CCL2 secretion elicited in response to HIV-1 gp120 in human primary macrophages.

Authors:  Laura Fantuzzi; Francesca Spadaro; Cristina Purificato; Serena Cecchetti; Franca Podo; Filippo Belardelli; Sandra Gessani; Carlo Ramoni
Journal:  Blood       Date:  2008-01-18       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.